Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.

Source:http://linkedlifedata.com/resource/pubmed/id/18056788

Download in:

View as

General Info

PMID
18056788